Avanos Medical (AVNS) Asset Writedowns and Impairment (2024)
Avanos Medical (AVNS) reported Asset Writedowns and Impairment of $336.5 million for Q4 2024.
Avanos Medical (AVNS) Asset Writedowns and Impairment (2024) Analysis & Trends
Avanos Medical (AVNS) has 1 years of Asset Writedowns and Impairment data on file, last reported at $336.5 million in Q4 2024.
- For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $336.5 million; the trailing twelve-month figure through Dec 2024 stood at $336.5 million (changed N/A YoY), and the FY2025 full-year result was $77.0 million, down 82.37% from the prior year.
- Asset Writedowns and Impairment was little changed at $336.5 million in Q4 2024.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $336.5 million in Q4 2024 to a low of $336.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 336.50 Mn |
| Dec 31, 2024 | 336.50 Mn |